RGD Reference Report - Intrathecal delivery of mesenchymal stromal cells protects the structure of altered perineuronal nets in SOD1 rats and amends the course of ALS. - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

Intrathecal delivery of mesenchymal stromal cells protects the structure of altered perineuronal nets in SOD1 rats and amends the course of ALS.

Authors: Forostyak, S  Homola, A  Turnovcova, K  Svitil, P  Jendelova, P  Sykova, E 
Citation: Forostyak S, etal., Stem Cells. 2014 Aug 11. doi: 10.1002/stem.1812.
RGD ID: 9590123
Pubmed: PMID:25113670   (View Abstract at PubMed)
PMCID: PMC4321196   (View Article at PubMed Central)
DOI: DOI:10.1002/stem.1812   (Journal Full-text)

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder resulting in a lethal outcome. We studied changes in ventral horn perineuronal nets (PNN) of superoxide dismutase 1 (SOD1) rats during the normal disease course and after the intrathecal application (5x105 cells) of human bone marrow mesenchymal stromal cells (MSCs) post symptom manifestation. We found that MSCs ameliorated disease progression, significantly improved motor activity and prolonged survival. For the first time, we report that SOD1 rats have an abnormal disorganized PNN structure around the spinal motoneurons and give different expression profiles of chondroitin sulfate proteoglycans (CSPGs), such as versican, aggrecan and phosphacan, but not link protein-1. Additionally, SOD1 rats had different profiles for CSPG gene expression (Versican, Hapln1, Neurocan and Tenascin-R), whereas Aggrecan and Brevican profiles remained unchanged. The application of MSCs preserved PNN structure, accompanied by better survival of motorneurons. We measured the concentration of cytokines (IL-1alpha, MCP-1, TNF-alpha, GM-CSF, IL-4 and IFN-gamma) in the rats' cerebrospinal fluid and found significantly higher concentrations of IL-1alpha and MCP-1. Our results show that PNN and cytokine homeostasis are altered in the SOD1 rat model of ALS. These changes could potentially serve as biological markers for the diagnosis, assessment of treatment efficacy and prognosis of ALS. We also show that the administration of human MSCs is a safe procedure that delays the loss of motor function and increases the overall survival of symptomatic ALS animals, by remodelling the recipients' pattern of gene expression and having neuroprotective and immunomodulatory effects. Stem Cells 2014.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
PTPRZ1Humanamyotrophic lateral sclerosis treatmentISOPtprz1 (Rattus norvegicus) RGD 
Ptprz1Ratamyotrophic lateral sclerosis treatmentIEP  RGD 
Ptprz1Mouseamyotrophic lateral sclerosis treatmentISOPtprz1 (Rattus norvegicus) RGD 

Objects Annotated

Genes (Rattus norvegicus)
Ptprz1  (protein tyrosine phosphatase, receptor type Z1)

Genes (Mus musculus)
Ptprz1  (protein tyrosine phosphatase receptor type Z, polypeptide 1)

Genes (Homo sapiens)
PTPRZ1  (protein tyrosine phosphatase receptor type Z1)


Additional Information